1050 related articles for article (PubMed ID: 36046791)
1. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
Li Z; Sun C; Qin Z
Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
[TBL] [Abstract][Full Text] [Related]
5. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment.
Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
Front Immunol; 2023; 14():1152312. PubMed ID: 37033960
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
8. Metabolic alterations in the tumor microenvironment and their role in oncogenesis.
Eisenberg L; Eisenberg-Bord M; Eisenberg-Lerner A; Sagi-Eisenberg R
Cancer Lett; 2020 Aug; 484():65-71. PubMed ID: 32387442
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
[TBL] [Abstract][Full Text] [Related]
10. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
11. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
12. Stromal reprogramming: A target for tumor therapy.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Dec; 239():117049. PubMed ID: 31730862
[TBL] [Abstract][Full Text] [Related]
13. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
Piper M; Mueller AC; Karam SD
Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
[TBL] [Abstract][Full Text] [Related]
14. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
Akkız H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.
Zhang W; Wang J; Liu C; Li Y; Sun C; Wu J; Wu Q
J Transl Med; 2023 Nov; 21(1):827. PubMed ID: 37978384
[TBL] [Abstract][Full Text] [Related]
16. The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators.
Ilkhani K; Bastami M; Delgir S; Safi A; Talebian S; Alivand MR
Anticancer Agents Med Chem; 2021; 21(2):254-266. PubMed ID: 32914721
[TBL] [Abstract][Full Text] [Related]
17. 'Reverse Warburg effect' of cancer‑associated fibroblasts (Review).
Liang L; Li W; Li X; Jin X; Liao Q; Li Y; Zhou Y
Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35425996
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Martinez-Zubiaurre I; Hellevik T
Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
[TBL] [Abstract][Full Text] [Related]
19. Dual Role of Fibroblasts Educated by Tumour in Cancer Behavior and Therapeutic Perspectives.
Toledo B; Picon-Ruiz M; Marchal JA; Perán M
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555218
[TBL] [Abstract][Full Text] [Related]
20. The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives.
Fang Z; Xu J; Zhang B; Wang W; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Nov; 13(1):154. PubMed ID: 33213510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
